QRG Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
31,772
+1,586
+5% +$106K 0.02% 459
2026
Q1
$1.9M Buy
30,186
+5,237
+21% +$365K 0.02% 430
2025
Q4
$1.66M Buy
24,949
+238
+1% +$15.4K 0.02% 445
2025
Q3
$1.66M Sell
24,711
-1,267
-5% -$100K 0.02% 419
2025
Q2
$2.27M Buy
25,978
+3,229
+14% +$253K 0.02% 451
2025
Q1
$1.55M Buy
22,749
+4,716
+26% +$385K 0.02% 500
2024
Q4
$1.4M Buy
18,033
+2,336
+15% +$173K 0.01% 519
2024
Q3
$1.05M Buy
15,697
+1,248
+9% +$102K 0.01% 580
2024
Q2
$1.64M Buy
14,449
+3,553
+33% +$449K 0.02% 458
2024
Q1
$1.51M Buy
10,896
+1,046
+11% +$131K 0.02% 470
2023
Q4
$1.22M Buy
9,850
+564
+6% +$57.6K 0.02% 494
2023
Q3
$866K Buy
+9,286
New +$1.05M 0.02% 521

Other funds holding DXCM

QRG Capital Management's DXCM Position: Q2 2026 in Review

QRG Capital Management increased its DexCom (DXCM) stake by 5.3% in Q2 2026, buying an estimated $106K and bringing the position to 31,772 shares worth $2.14M. The position accounts for 0.02% of the portfolio, ranked #459.

QRG Capital Management first reported a position in DXCM in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.27M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • QRG Capital Management held 31,772 shares of DexCom worth $2.14M as of Q2 2026.
  • QRG Capital Management bought 1,586 DexCom shares in Q2 2026, an estimated $106K.
  • DexCom made up 0.02% of QRG Capital Management's portfolio in Q2 2026, its #459 holding.
  • QRG Capital Management first reported a position in DexCom in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's DexCom position peaked at $2.27M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.